Prasugrel hydrochloride for the treatment of sickle cell disease

Conran, N; Rees, DC

Conran, N (reprint author), Univ Estadual Campinas, UNICAMP, Hematol Ctr, Cidade Univ, Campinas, SP, Brazil.; Rees, DC (reprint author), Kings Coll Hosp London, Dept Paediat Haematol, London, England.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017; 26 (7): 865

Abstract

Introduction: Therapeutic options for sickle cell disease (SCD) are limited and, currently, only one drug (hydroxyurea) has FDA approval for the treat......

Full Text Link